E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/30/2019 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse $2.25 million contingent coupon autocallable yield notes on three stocks

By Sarah Lizee

Olympia, Wash., Dec. 30 – Credit Suisse AG, London Branch priced $2.25 million of contingent coupon autocallable yield notes due Dec. 30, 2022 linked to the lowest performing of the stocks of AbbVie Inc., Amgen Inc. and Bristol-Myers Squibb Co., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a quarterly coupon at an annualized rate of 12.5% if each stock closes at or above its barrier level, 60% of its initial level, on a related observation date.

Starting June 23, 2020, the notes will be called at par plus the coupon if each stock closes at or above 100% of its initial level on any quarterly observation date other than the final one.

The payout at maturity will be par unless any stock finishes below its 60% knock-in level, in which case the payout will be par plus the return of the least performing stock with full exposure to losses.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:Credit Suisse AG, London Branch
Issue:Contingent coupon autocallable yield notes
Underlying stocks:AbbVie Inc., Amgen Inc. and Bristol-Myers Squibb Co.
Amount:$2,252,000
Maturity:Dec. 30, 2022
Coupon:12.5% per year, payable quarterly if each stock closes at or above its coupon barrier level on observation date
Price:Par
Payout at maturity:Par unless any stock finishes below its knock-in level, in which case the payout will be par plus the return of the least performing stock with full exposure to losses
Call:Starting June 23, 2020, at par plus coupon if each stock closes at or above 100% of initial level on any quarterly observation date other than final one
Initial levels:$89.29 for AbbVie, $243.06 for Amgen, $63.51 for Bristol-Myers
Coupon barrier/knock-in levels:$53.574 for AbbVie, $145.836 for Amgen, $38.106 for Bristol-Myers, 60% of initial levels
Pricing date:Dec. 20
Settlement date:Dec. 30
Agent:Credit Suisse Securities (USA) LLC
Fees:1.5%
Cusip:22551NEJ1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.